Tyra Biosciences Inc
NASDAQ:TYRA
Tyra Biosciences Inc
NASDAQ:TYRA
Price:
21
USD
-5.83%
Market Closed
Market Cap:
$1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Intrinsic Value
Not Available for TYRA
There is not enough data to reliably calculate the intrinsic value for Tyra Biosciences Inc.
Do our valuations actually work? See backtest results .
Alternatives to TYRA
Fundamental Analysis
What Tyra Biosciences Does
Tyra Biosciences is a clinical-stage drug company that designs medicines for cancers and other diseases driven by abnormal growth signals. Its main focus is on the FGFR family of targets, which are proteins that can help certain tumors grow when they are altered. The company is building small-molecule drugs that are meant to block those signals in a more selective way than older therapies.
- Headquarters
- United States of America US
- Employees
- 87
- IPO date
- Sep 15, 2021
Financials
Efficiency
Earnings Waterfall
Tyra Biosciences Inc
Tyra Biosciences Inc
